Impact of non-compliance on the clinical and cost-effectiveness of statins
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
StandardStandard
Impact of non-compliance on the clinical and cost-effectiveness of statins. / Hughes, D.; Hughes, D.A.
2001. Papur a gyflwynwyd yn International Society for Pharmacoeconomics and Outcomes Research, Cannes, France.
2001. Papur a gyflwynwyd yn International Society for Pharmacoeconomics and Outcomes Research, Cannes, France.
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
HarvardHarvard
Hughes, D & Hughes, DA 2001, 'Impact of non-compliance on the clinical and cost-effectiveness of statins', Papur a gyflwynwyd yn International Society for Pharmacoeconomics and Outcomes Research, Cannes, France, 3/01/01.
APA
Hughes, D., & Hughes, D. A. (2001). Impact of non-compliance on the clinical and cost-effectiveness of statins. Papur a gyflwynwyd yn International Society for Pharmacoeconomics and Outcomes Research, Cannes, France.
CBE
Hughes D, Hughes DA. 2001. Impact of non-compliance on the clinical and cost-effectiveness of statins. Papur a gyflwynwyd yn International Society for Pharmacoeconomics and Outcomes Research, Cannes, France.
MLA
Hughes, D. a D.A. Hughes Impact of non-compliance on the clinical and cost-effectiveness of statins. International Society for Pharmacoeconomics and Outcomes Research, Cannes, France, 03 Ion 0001, Papur, 2001.
VancouverVancouver
Hughes D, Hughes DA. Impact of non-compliance on the clinical and cost-effectiveness of statins. 2001. Papur a gyflwynwyd yn International Society for Pharmacoeconomics and Outcomes Research, Cannes, France.
Author
RIS
TY - CONF
T1 - Impact of non-compliance on the clinical and cost-effectiveness of statins
AU - Hughes, D.
AU - Hughes, D.A.
PY - 2001/11/1
Y1 - 2001/11/1
M3 - Paper
T2 - International Society for Pharmacoeconomics and Outcomes Research, Cannes, France
Y2 - 3 January 0001
ER -